Aditxt, Inc. Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement
Aditxt, Inc. (ADTX) had Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement of $6.50 million as of 2021-08-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Loan, Held-in-Portfolio, Principal Outstanding
us-gaap:PrincipalAmountOutstandingOnLoansSecuritized · last filed 2023-04-17
- 2021-08-30: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $6.50M.
- 2021-08-27: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $6.50M.
| Period end | Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement |
|---|---|
| 2021-08-30 | $6.50M 10-Q · filed 2022-08-15 |
| 2021-08-27 | $6.50M 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |